What mifepristone fight’s really about: Why Maryland must protect providers, patients

By: Amy Hagstrom Miller, Christie Pitney

Outlets: Maryland Matters

Published: June 8, 2026

Words: 870

Last Updated: 2 days, 13 hours ago

Body Text Preview

On May 1, the ultraconservative 5th U.S. Circuit Court of Appeals did something equal parts unprecedented and outrageous: It overruled the scientific and medical expertise of the Food and Drug Administration, reinstating a nationwide ban on mailing mifepristone, a safe, effective medication used in most U.S. abortions and early miscarriage care. The ruling also banned filling a prescription for mifepristone at a retail pharmacy.

While the U.S. Supreme Court blocked this decision from taking effect …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

Email Us